Arti Lynn

Arti Lynn is an experienced medical professional specializing in various therapeutic areas, including oncology, virology, rheumatology, dermatology, immunology, and inflammation. Currently serving as a Principal Medical Scientist at Gilead Sciences since August 2019, Arti has a robust background in medical science liaison roles at leading pharmaceutical companies, including Kiniksa Pharmaceuticals, SUN PHARMA, Celgene, Genzyme, Express Scripts/Curascript, and PharMerica. Arti holds a Doctor of Pharmacy (PharmD) degree from the University of Florida.